Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Varex Imaging (VREX) Operating Income (2016 - 2026)

Varex Imaging has reported Operating Income over the past 11 years, most recently at $15.4 million for Q1 2026.

  • Quarterly Operating Income rose 37.5% to $15.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$23.6 million through Jan 2026, down 160.36% year-over-year, with the annual reading at -$27.8 million for FY2025, 186.6% down from the prior year.
  • Operating Income was $15.4 million for Q1 2026 at Varex Imaging, down from $19.6 million in the prior quarter.
  • Over five years, Operating Income peaked at $26.6 million in Q2 2022 and troughed at -$80.7 million in Q3 2025.
  • The 5-year median for Operating Income is $15.5 million (2023), against an average of $10.7 million.
  • The largest YoY upside for Operating Income was 187.01% in 2025 against a maximum downside of 967.74% in 2025.
  • A 5-year view of Operating Income shows it stood at $13.0 million in 2022, then plummeted by 67.69% to $4.2 million in 2023, then skyrocketed by 159.52% to $10.9 million in 2024, then skyrocketed by 79.82% to $19.6 million in 2025, then decreased by 21.43% to $15.4 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Operating Income are $15.4 million (Q1 2026), $19.6 million (Q4 2025), and -$80.7 million (Q3 2025).